Nebenwirkungen · Ibandronic Acid Teva
Ibandronic Acid Teva 150 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 19
HOS-212599 · Präparat HOS-154930
System Organ Common Uncommon Rare Very rare Not known Class Immune Asthma Hypersensitivity Anaphylactic system exacerbation reaction reaction/shock*† disorders Metabolism Hypocalcaemia† and nutrition disorders Nervous Headache Dizziness system disorders Eye disorders Ocular inflammation*† Gastrointestina Oesophagit Oesophagitis Duodenitis l disorders* is, Gastritis, including Gastro oesophageal oesophagea ulcerations or l reflux strictures and disease, dysphagia, Dyspepsia, Vomiting, Diarrhoea, Flatulence Abdominal pain, Nausea Skin and Rash Angioedema, Stevens-Johnson subcutaneous Face oedema, syndrome†, tissues Urticaria Erythema disorders multiforme†, Dermatitis bullous† Musculoskelet Arthralgia, Back pain Atypical Osteonecrosis of Atypical al and Myalgia, subtrochanteric jaw*†, fractures of connective Musculosk and diaphyseal Osteonecrosis of long bones tissue eletal pain, femoral the external other than disorders Muscle fractures† auditory canal the femur cramp, (bisphosphonate Musculosk class adverse eletal reaction)† stiffness General Influenza Fatigue disorders and like illness* administration site conditions *See further information below †Identified in post-marketing experience.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-08-28T16:00:09Z · SHA-256 a77d86843d2ecd9a9cc76a7966a88b66429aafa008e6f882df206e72867ec593 · Passage e187241c1137c236fe97e2ded13b826c48c55f8dfbc0f0a51e548689355331e9 · Zeichen 2114–4731 im Abschnitt